Skip to main content
. Author manuscript; available in PMC: 2013 May 6.
Published in final edited form as: J Pediatr. 2011 Dec 16;160(5):774–780.e11. doi: 10.1016/j.jpeds.2011.11.005

TABLE 5.

Interventions and discharge characteristics among VLBW Infants with T21, T18, T13, triploidy and infants without chromosomal anomalies in the Vermont Oxford Network born 1994–2009

Group
Type of Intervention/ Discharge
Characteristic, N (%)
T21
N=1681
T18
N=1416
T13
N=435
Triploidy
N=116
No Chromosomal
Anomaly*
N=533916
Delivery Room (DR) Interventions
  Cesarean section delivery 1200 (71.5) 910 (64.3) 239 (54.9) 71 (61.2) 353451 (66.2)
  Oxygen given 1331 (79.5) 1049 (74.2) 282 (64.8) 82 (70.7) 472540 (88.7)
  Face mask ventilation 705 (42.1) 820 (58.1) 208 (47.8) 66 (56.9) 299449 (56.2)
  Endotracheal tube ventilation 577 (34.5) 678 (48.0) 185 (42.5) 58 (50.0) 292586 (54.9)
  Epinephrine given 34 (2.0) 94 (6.6) 13 (3.0) 4 (3.4) 20449 (3.8)
  Cardiac compression 55 (3.3) 132 (9.3) 31 (7.1) 5 (4.3) 31869 (6.0)
  DR surfactant1 232 (16.6) 136 (11.7) 47 (13.1) 23 (24.7) 127194 (29.8)
  Any type of DR intervention 1352 (80.8) 1070 (75.7) 289 (66.6) 84 (72.4) 484409 (90.9)
  Surfactant at any time 614 (36.6) 513 (36.3) 169 (39.2) 52 (45.2) 336310 (63.1)

NICU Interventions among DR Survivors
N=1515 N=1106 N=302 N=85 N=512537
  Oxygen 1300 (85.8) 990 (89.5) 272 (90.1) 76 (89.4) 457574 (89.3)
  Conventional ventilation 915 (60.4) 774 (70.0) 232 (76.8) 65 (76.5) 350303 (68.4)
  High frequency ventilation 275 (18.2) 233 (21.1) 65 (21.5) 24 (28.2) 117314 (22.9)
  Any type of ventilation 937 (61.8) 804 (72.7) 240 (79.5) 68 (80.0) 363565 (70.9)
  High flow nasal cannula2 288 (44.2) 75 (17.5) 16 (12.2) 1 (3.7) 91487 (45.0)
  Nasal IMV or nasal SIMV2 75 (11.5) 21 (4.9) 4 (3.1) 0 (0.0) 27632 (13.6)
  Inhaled nitric oxide3 43 (11.7) 10 (4.3) 5 (7.4) 2 (16.7) 4987 (4.7)
  Nasal CPAP4 719 (47.5) 259 (23.4) 55 (18.2) 13 (15.3) 317674 (62.0)
  Early nasal CPAP5 283 (49.1) 117 (53.9) 29 (60.4) 3 (42.9) 82441 (35.6)
  Any type of respiratory support 1335 (88.1) 999 (90.3) 277 (91.7) 78 (91.8) 469488 (91.6)

Discharge Characteristics among DR Survivors
N=1515 N=1106 N=302 N=85 N=512537
  Oxygen at discharge6 608 (40.2) 704 (63.8) 212 (70.2) 64 (75.3) 135996 (26.6)
  Monitor at discharge6 752 (52.8) 698 (68.2) 210 (74.5) 59 (75.6) 223776 (46.7)
  Enteral feeding at discharge7
    None 258 (23.3) 547 (72.5) 169 (80.1) 44 (77.2) 46776 (13.4)
    Human milk only 74 (6.7) 43 (5.7) 14 (6.6) 2 (3.5) 30905 (8.8)
    Formula only 435 (39.3) 122 (16.2) 24 (11.4) 6 (10.5) 160202 (45.8)
    Human milk with fortifier or formula 340 (30.7) 42 (5.6) 4 (1.9) 5 (8.8) 111724 (32.0)
*

Excludes 336 infants with missing information on birth defects. Information was missing in the chromosomal anomaly groups shown for oxygen: 9 infants; face mask ventilation 10; endotracheal tube ventilation: 10; epinephrine: 9; cardiac compression: 10; DR surfactant: 5; any type of DR intervention: 10; surfactant at any time: 10; discharge oxygen: 6; discharge monitor: 5; enteral feeding: 19; high frequency vent: 1; high flow nasal cannula: 1; nasal IMV: 2. Missing information not reported for infants in the no chromosomal anomaly group.

1

Variable added in 2000.

2

Variable added in 2006; IMV: intermittent mandatory ventilation; SIMV: synchronized intermittent mandatory ventilation.

3

Variable added in 2008.

4

CPAP: continuous positive airway pressure. For the purpose of this definition, nasal IMV and SIMV are both considered forms of nasal CPAP.

5

Variable added in 2002, coded if nasal CPAP yes and if before endotracheal tube ventilation.

6

Variable added in 1997; for infants who died before discharge, item is checked yes if the infant received supplemental oxygen or was on an apnea monitor or cardio-respiratory monitor at any time on the day of death.

7

Variable added in 2002; based on enteral feedings received during the 24 hour period prior to discharge, transfer or death and is not applicable if infant died in the DR.